Hong Kong · Delayed Price · Currency is HKD Yonghe Medical Group Statistics
Total Valuation
HKG:2279 has a market cap or net worth of HKD 1.07 billion. The enterprise value is 717.48 million.
| Market Cap | 1.07B |
| Enterprise Value | 717.48M |
Important Dates
The last earnings date was Tuesday, March 31, 2026.
| Earnings Date | Mar 31, 2026 |
| Ex-Dividend Date | May 26, 2026 |
Share Statistics
HKG:2279 has 500.11 million shares outstanding. The number of shares has decreased by -0.13% in one year.
| Current Share Class | 500.11M |
| Shares Outstanding | 500.11M |
| Shares Change (YoY) | -0.13% |
| Shares Change (QoQ) | -0.04% |
| Owned by Insiders (%) | 41.44% |
| Owned by Institutions (%) | 0.01% |
| Float | 109.11M |
Valuation Ratios
The trailing PE ratio is 12.99 and the forward PE ratio is 9.86.
| PE Ratio | 12.99 |
| Forward PE | 9.86 |
| PS Ratio | 0.53 |
| PB Ratio | 1.22 |
| P/TBV Ratio | 1.25 |
| P/FCF Ratio | 2.00 |
| P/OCF Ratio | 1.93 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 1.77, with an EV/FCF ratio of 1.35.
| EV / Earnings | 8.75 |
| EV / Sales | 0.36 |
| EV / EBITDA | 1.77 |
| EV / EBIT | 5.19 |
| EV / FCF | 1.35 |
Financial Position
The company has a current ratio of 1.55, with a Debt / Equity ratio of 0.62.
| Current Ratio | 1.55 |
| Quick Ratio | 1.47 |
| Debt / Equity | 0.62 |
| Debt / EBITDA | 1.33 |
| Debt / FCF | 1.01 |
| Interest Coverage | 5.39 |
Financial Efficiency
Return on equity (ROE) is 9.80% and return on invested capital (ROIC) is 18.22%.
| Return on Equity (ROE) | 9.80% |
| Return on Assets (ROA) | 4.53% |
| Return on Invested Capital (ROIC) | 18.22% |
| Return on Capital Employed (ROCE) | 10.77% |
| Weighted Average Cost of Capital (WACC) | 5.58% |
| Revenue Per Employee | 623,399 |
| Profits Per Employee | 25,411 |
| Employee Count | 3,228 |
| Asset Turnover | 1.06 |
| Inventory Turnover | 20.51 |
Taxes
In the past 12 months, HKG:2279 has paid 35.48 million in taxes.
| Income Tax | 35.48M |
| Effective Tax Rate | 30.24% |
Stock Price Statistics
The stock price has increased by +119.59% in the last 52 weeks. The beta is 0.45, so HKG:2279's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | +119.59% |
| 50-Day Moving Average | 1.93 |
| 200-Day Moving Average | 2.13 |
| Relative Strength Index (RSI) | 63.67 |
| Average Volume (20 Days) | 396,675 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2279 had revenue of HKD 2.01 billion and earned 82.03 million in profits. Earnings per share was 0.16.
| Revenue | 2.01B |
| Gross Profit | 1.33B |
| Operating Income | 138.18M |
| Pretax Income | 117.34M |
| Net Income | 82.03M |
| EBITDA | 263.62M |
| EBIT | 138.18M |
| Earnings Per Share (EPS) | 0.16 |
Balance Sheet
The company has 886.34 million in cash and 539.35 million in debt, with a net cash position of 347.00 million or 0.69 per share.
| Cash & Cash Equivalents | 886.34M |
| Total Debt | 539.35M |
| Net Cash | 347.00M |
| Net Cash Per Share | 0.69 |
| Equity (Book Value) | 876.20M |
| Book Value Per Share | 1.75 |
| Working Capital | 338.52M |
Cash Flow
In the last 12 months, operating cash flow was 551.43 million and capital expenditures -19.77 million, giving a free cash flow of 531.66 million.
| Operating Cash Flow | 551.43M |
| Capital Expenditures | -19.77M |
| Depreciation & Amortization | 129.17M |
| Net Borrowing | -246.19M |
| Free Cash Flow | 531.66M |
| FCF Per Share | 1.06 |
Margins
Gross margin is 66.04%, with operating and profit margins of 6.87% and 4.08%.
| Gross Margin | 66.04% |
| Operating Margin | 6.87% |
| Pretax Margin | 5.83% |
| Profit Margin | 4.08% |
| EBITDA Margin | 13.10% |
| EBIT Margin | 6.87% |
| FCF Margin | 26.42% |
Dividends & Yields
This stock pays an annual dividend of 0.09, which amounts to a dividend yield of 4.47%.
| Dividend Per Share | 0.09 |
| Dividend Yield | 4.47% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.13% |
| Shareholder Yield | 4.56% |
| Earnings Yield | 7.70% |
| FCF Yield | 49.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:2279 has an Altman Z-Score of 1.59 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.59 |
| Piotroski F-Score | 7 |